Wednesday 26 August 2015

Beta blockers appear to lengthen survival in ovarian cancer

The survival advantage appears to be linked to the use of non-selective beta-blockers

Related items from OnMedica

Beta blockers linked to lower dementia risk
Be alert to ovarian cancer, MDU warns GPs
HRT short-term use raises risk of ovarian cancer, warns study
Blood test could boost early detection of ovarian cancer
Experts disappointed at NICE decision on ovarian cancer drug
via OnMedica News Read More Here..

No comments:

Post a Comment